Qelbree

Active Ingredient(s): Viloxazine Hydrochloride
FDA Approved: * April 2, 2021
Pharm Company: * SUPERNUS PHARMS
Category: ADD / ADHD

Viloxazine, sold under the brand name Qelbree among others, is a medication which is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and depression.[1][5] It was marketed for more than two decades as an antidepressant in Europe before being repurposed as a treatment for ADHD and launched in the United States in April 2021.[5][1][6][7] Viloxazine is taken by mout... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Qelbree 100 mg Oral Capsule, Extended Release
NDC: 17772-131
Labeler:
Supernus Pharmaceuticals, Inc
Qelbree 150 mg Oral Capsule, Extended Release
NDC: 17772-132
Labeler:
Supernus Pharmaceuticals, Inc
Qelbree 200 mg Oral Capsule, Extended Release
NDC: 17772-133
Labeler:
Supernus Pharmaceuticals, Inc